007390 — NatureCell Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual cashflow statement for NatureCell Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-18,870	-32,031	-6,814	-11,680	1,226
Depreciation
Amortisation
Non-Cash Items	15,178	23,271	-3,294	2,275	511
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-3,280	-3,238	-6,090	5,527	-2,124
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-5,412	-10,150	-14,866	-2,128	1,513
Capital Expenditures	-2,722	-455	-3,795	-6,125	-3,121
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	18,228	5,279	-11,540	21,704	-541
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	15,506	4,823	-15,335	15,579	-3,662
Financing Cash Flow Items	-0.002	0	42	-10	40
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	10,278	-3,710	29,071	-14,935	190
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	20,268	-8,947	-1,295	-1,364	-1,521